We're proud to share that AYMES International presented two abstracts at this year's ESPEN Congress on Clinical Nutrition & Metabolism, held in Berlin from 5–8 September 2026, which was a great opportunity to showcase our ongoing commitment to evidence-based innovation in oral nutritional supplements.
Megan Lindsay, Medical Nutrition Manager at the AYMES poster station, ESPEN Congress 2026, Berlin
PD171 — ActaGain 2.0 Plant-Powered1
Our PD171 abstract introduced our newly launched ActaGain 2.0 Plant-Powered, exploring a soya-based, plant-derived alternative to traditional dairy-based oral nutritional supplements, reflecting growing interest across the clinical nutrition community in sustainable, plant-based options for patients with or at risk of disease-related malnutrition.
PD164 — ActaGain Protein Compact2
The PD164 abstract focused on our ActaGain Protein Compact, which launched in June this year, looking at tolerability and acceptability of a high-protein, low-volume format across two prospective studies.
Both abstracts were accepted following peer review, and we were delighted to present them to colleagues from across the clinical nutrition field. Full poster content is now available to view via AYMES Academy. In due course, both abstracts will also be published, with unique DOIs, in a dedicated ESPEN supplement of Clinical Nutrition ESPEN.
Thank you to everyone who stopped by to talk to us in Berlin! It's always energising to connect with the HCP community and hear your perspectives on where clinical nutrition is heading next.